Validation of an in vitro tracheal model for the study of innate host defence mechanism in respiratory tract infections

K. Akram, P. Anujan, B. Mccloskey, L. Bingle, C. Bingle (Sheffield, United Kingdom)

Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Session: Cells, biofilms and biomarkers in respiratory infections
Session type: Thematic Poster Session
Number: 2498

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Akram, P. Anujan, B. Mccloskey, L. Bingle, C. Bingle (Sheffield, United Kingdom). Validation of an in vitro tracheal model for the study of innate host defence mechanism in respiratory tract infections. Eur Respir J 2014; 44: Suppl. 58, 2498

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
An innate defence role for BPIFA1/SPLUNC1 against influenza-A virus infection
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015


Pneumolysin causes cyotoxicity and ciliary stasis in human respiratory epithelial cells
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014


Some aspects of mucosal immune response in children with bacterial upper respiratory tract infections
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019


Makrophages regulate epithelial defence of the respiratory tract
Source: Annual Congress 2008 - Airway cell biology
Year: 2008


The ancient rubredoxin system: An efficient defense mechanism of pseudomonas aeruginosa during infections
Source: International Congress 2014 – Immunology of respiratory infections
Year: 2014

The innate defence peptide BPIFA1/SPLUNC1 restricts respiratory viral infections
Source: International Congress 2019 – Infections, the microbiome and host defence peptides in the development and progression of asthma
Year: 2019


Pathogen profile of lung infections in systemic autoimmune diseases
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014

Innate immunity in the lung: how epithelial cells fight against respiratory pathogens
Source: Eur Respir J 2004; 23: 327-333
Year: 2004



Efficacy of IFN-λ1 to protect human airway epithelial cells against rhinovirus 1B infection
Source: Annual Congress 2013 –Viral infections
Year: 2013


Fluticasone propionate alters the respiratory tract microbiota and has dose-related effects on anti-bacterial host defence
Source: International Congress 2016 – Translational research in respiratory infections
Year: 2016

A human lung explant model for the study of antiviral drugs
Source: Annual Congress 2013 –Interesting research questions
Year: 2013


Epigenetic control of antiviral and innate immune response following viral infection in a lung epithelial model
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013


RSV infection modulates IL-15 production and MICA levels in respiratory epithelial cells
Source: Eur Respir J 2012; 39: 712-720
Year: 2012



Respiratory viruses and asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=223
Year: 2003

Prevention of paediatric respiratory tract infections: emphasis on the role of OM-85
Source: Eur Respir Rev 2005; 14: 74-77
Year: 2005



Respiratory infections in the immunocompromised host
Source: ERS Course 2018 - Respiratory Infections
Year: 2018

Influenza virus infection of human ciliated respiratory epithelial cells in culture
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013


Epithelial NF-κB regulates bacterial translocation in the respiratory tract
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013